Waxman J - Search Results

1

Impact of analytical bias in metabonomic studies of human blood serum and plasma.

Teahan O, Gamble S, Holmes E, Waxman J, Nicholson JK, Bevan C, Keun HC. Teahan O, et al. Among authors: waxman j. Anal Chem. 2006 Jul 1;78(13):4307-18. doi: 10.1021/ac051972y. Anal Chem. 2006. PMID: 16808437

2

Metabolic signatures of malignant progression in prostate epithelial cells.

Teahan O, Bevan CL, Waxman J, Keun HC. Teahan O, et al. Among authors: waxman j. Int J Biochem Cell Biol. 2011 Jul;43(7):1002-9. doi: 10.1016/j.biocel.2010.07.003. Epub 2010 Jul 13. Int J Biochem Cell Biol. 2011. PMID: 20633696

3

Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.

Whitaker HC, Hanrahan S, Totty N, Gamble SC, Waxman J, Cato AC, Hurst HC, Bevan CL. Whitaker HC, et al. Among authors: waxman j. Clin Cancer Res. 2004 Nov 1;10(21):7392-401. doi: 10.1158/1078-0432.CCR-04-0388. Clin Cancer Res. 2004. PMID: 15534116

4

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Dart DA, Spencer-Dene B, Gamble SC, Waxman J, Bevan CL. Dart DA, et al. Among authors: waxman j. Endocr Relat Cancer. 2009 Dec;16(4):1157-69. doi: 10.1677/ERC-09-0028. Epub 2009 Jul 27. Endocr Relat Cancer. 2009. PMID: 19635783 Free PMC article.

5

Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer.

Pchejetski D, Nunes J, Sauer L, Sidhu J, Sharma A, Keun HC, Waxman J, Stebbing J. Pchejetski D, et al. Among authors: waxman j. Breast Cancer Res Treat. 2010 Nov;124(2):543-9. doi: 10.1007/s10549-010-0968-y. Epub 2010 Jun 10. Breast Cancer Res Treat. 2010. PMID: 20535545

6

Visualising androgen receptor activity in male and female mice.

Dart DA, Waxman J, Aboagye EO, Bevan CL. Dart DA, et al. Among authors: waxman j. PLoS One. 2013 Aug 7;8(8):e71694. doi: 10.1371/journal.pone.0071694. Print 2013. PLoS One. 2013. PMID: 23940781 Free PMC article.

7

Androgens target prohibitin to regulate proliferation of prostate cancer cells.

Gamble SC, Odontiadis M, Waxman J, Westbrook JA, Dunn MJ, Wait R, Lam EW, Bevan CL. Gamble SC, et al. Among authors: waxman j. Oncogene. 2004 Apr 15;23(17):2996-3004. doi: 10.1038/sj.onc.1207444. Oncogene. 2004. PMID: 14968116 Free article.

8

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.

Gamble SC, Chotai D, Odontiadis M, Dart DA, Brooke GN, Powell SM, Reebye V, Varela-Carver A, Kawano Y, Waxman J, Bevan CL. Gamble SC, et al. Among authors: waxman j. Oncogene. 2007 Mar 15;26(12):1757-68. doi: 10.1038/sj.onc.1209967. Epub 2006 Sep 11. Oncogene. 2007. PMID: 16964284

9

FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.

Brooke GN, Culley RL, Dart DA, Mann DJ, Gaughan L, McCracken SR, Robson CN, Spencer-Dene B, Gamble SC, Powell SM, Wait R, Waxman J, Walker MM, Bevan CL. Brooke GN, et al. Among authors: waxman j. Cancer Res. 2011 Feb 1;71(3):914-24. doi: 10.1158/0008-5472.CAN-10-0874. Epub 2010 Dec 17. Cancer Res. 2011. PMID: 21169411 Free article.

10

Circulating nucleic acids as biomarkers of prostate cancer.

Sita-Lumsden A, Fletcher CE, Dart DA, Brooke GN, Waxman J, Bevan CL. Sita-Lumsden A, et al. Among authors: waxman j. Biomark Med. 2013 Dec;7(6):867-77. doi: 10.2217/bmm.13.104. Biomark Med. 2013. PMID: 24266819 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters